PharmaCyte Biotech, Inc. PMCB
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 127.03% | 138.65% | 22.57% | -25.11% | -58.82% |
| Total Receivables | -90.69% | -93.48% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -86.57% | -56.70% | -23.48% | 2.01% | -0.83% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 62.12% | 67.24% | 22.01% | 7.92% | -41.88% |
|
|
|||||
| Total Current Assets | 62.12% | 67.24% | 22.01% | 7.92% | -41.88% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.05% | 6.42% | 66.86% | 44.79% | -27.52% |
| Total Assets | -18.62% | -15.25% | 27.48% | 1.59% | -35.73% |
|
|
|||||
| Total Accounts Payable | -16.06% | -32.09% | 147.49% | 192.97% | -16.03% |
| Total Accrued Expenses | 0.00% | -4.47% | -51.27% | -51.12% | -49.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -87.00% | -97.12% | -- | -94.34% | -95.99% |
| Total Other Current Liabilities | -87.00% | -97.12% | -- | -94.34% | -95.99% |
| Total Current Liabilities | -27.54% | -71.64% | 40.51% | -66.97% | -85.80% |
|
|
|||||
| Total Current Liabilities | -27.54% | -71.64% | 40.51% | -66.97% | -85.80% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1,237.99% | 2,915.43% | 520.51% | 159.71% | -95.27% |
| Total Liabilities | 354.06% | 259.21% | 360.30% | 66.76% | -91.14% |
|
|
|||||
| Common Stock & APIC | 0.25% | 0.68% | 0.95% | -0.41% | -0.64% |
| Retained Earnings | -17.30% | -22.86% | -3.39% | -7.55% | -1.22% |
| Treasury Stock & Other | 0.04% | 0.04% | -0.35% | 0.04% | -4.25% |
| Total Common Equity | -35.94% | -35.03% | -4.27% | -17.95% | -8.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.94% | -35.03% | -4.27% | -17.95% | -8.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -31.60% | -32.59% | -2.11% | -15.87% | -17.82% |
|
|
|||||